[vc_row][vc_column][vc_column_text] Inventor ANGELIDES KIMON [US] Número de Publicación US2020273540 (A1) Solicitante VIVANTE HEALTH INC [US] Abstract The invention is related to a system for treating irritable bowel syndrome, Crohn's disease, ulcerative colitis (collectively, inflammatory bowel disease, or “IBD”) by determining a number of indicators, including genetic markers, gene expression levels, levels of certain compounds in the gut or feces, hydrogen and/or methane levels, and concentrations of particular bacteria in the gut or feces and correlating… Resumen Sistema para tratar trastornos digestivos analizando una serie de...
Leer más





